Cellaviva is Scandinavia’s leading private biobank specializing in family stem cell preservation from the afterbirth, including umbilical cord blood, cord tissue and placenta.
With full regulatory approval from the Swedish Health and Social Care Inspectorate (IVO), Cellaviva is the only biobank of its kind in Sweden. Our services are grounded in the latest scientific standards and aim to provide families with long-term health security through access to future medical treatments.
In addition to stem cell banking, Cellaviva offers a growing portfolio of genetic tests and preventive health services designed to support proactive healthcare and early intervention.
We work in close collaboration with healthcare providers, public authorities, and research institutions to ensure quality, safety, and ethical excellence in everything we do.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Karolinska Institutet Science Park, Hälsovägen 7,sweden
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- cellaviva.se
- Keywords
- biobank, stamceller, familjesparande, vävnadsinrättning, cord blood, cord tissue, stem cell, stem cell bank, cord blood bank, family bank, placenta, tissue establishment.
- HQ
- Huddinge
Cellaviva Questions
Cellaviva's website is cellaviva.se
Cellaviva's LinkedIn profile is https://se.linkedin.com/company/cellaviva-ab
Cellaviva has
12 employees.
View email and phone details for 12
employees at Cellaviva.
Cellaviva's industry is
Hospitals and Health Care
Cellaviva's top competitors are
Smartcella Holding Ab,
Diamyd Medical,
Northx Biologics,
Nextcell Pharma Ab,
Swedenbio,
Qvance,
Atlas Antibodies,
Anocca,
Cellcolabs,
Atmp Sweden.
Cellaviva's categories are Hospitals and Health Care
Cellaviva's founding year is 2014
